165 related articles for article (PubMed ID: 38494290)
21. Autoimmune Encephalitis and Autoantibodies: A Review of Clinical Implications.
Hébert J; Muccilli A; Wennberg RA; Tang-Wai DF
J Appl Lab Med; 2022 Jan; 7(1):81-98. PubMed ID: 34996085
[TBL] [Abstract][Full Text] [Related]
22. General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis.
Masciocchi S; Businaro P; Scaranzin S; Morandi C; Franciotta D; Gastaldi M
Crit Rev Clin Lab Sci; 2024 Jan; 61(1):45-69. PubMed ID: 37777038
[TBL] [Abstract][Full Text] [Related]
23. Paraneoplastic and autoimmune encephalitis: Alterations of mood and emotion.
Marinas JE; Matveychuk D; McCombe JA; Tymchuk S; Dursun SM; Baker GB
Handb Clin Neurol; 2021; 183():221-234. PubMed ID: 34389119
[TBL] [Abstract][Full Text] [Related]
24. Antibody-Negative Autoimmune Encephalitis: A Single-Center Retrospective Analysis.
Mojžišová H; Krýsl D; Hanzalová J; Dargvainiene J; Wandinger KP; Leypoldt F; Elišák M; Marusič P
Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37879962
[TBL] [Abstract][Full Text] [Related]
25. Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes.
Villagrán-García M; Farina A; Campetella L; Arzalluz-Luque J; Honnorat J
Rev Neurol (Paris); 2024; 180(1-2):107-116. PubMed ID: 38142198
[TBL] [Abstract][Full Text] [Related]
26. PSYCHIATRIC DISORDERS IN AUTOIMMUNE ENCEPHALITIS - LITERATURE REVIEW.
Wcisło S; Bojkowska-Otrębska K; Łabuz-Roszak B
Pol Merkur Lekarski; 2023; 51(5):563-568. PubMed ID: 38069859
[TBL] [Abstract][Full Text] [Related]
27. [Autoimmune encephalitis : an update].
Mattar A; Honnorat J; Joubert B
Rev Prat; 2022 Jan; 72(1):85-90. PubMed ID: 35258262
[TBL] [Abstract][Full Text] [Related]
28. Application of the 2016 diagnostic approach for autoimmune encephalitis from Lancet Neurology to Chinese patients.
Li L; Sun L; Du R; Zheng Y; Dai F; Ma Q; Wang J
BMC Neurol; 2017 Nov; 17(1):195. PubMed ID: 29110638
[TBL] [Abstract][Full Text] [Related]
29. Challenging diagnosis and treatment decision of a long-history autoantibody-negative autoimmune encephalitis: Expert commentary.
Abboud H
Parkinsonism Relat Disord; 2023 Feb; 107():105278. PubMed ID: 36609094
[No Abstract] [Full Text] [Related]
30. Diagnostic and Therapeutic Approach to Autoimmune Neurologic Disorders.
López-Chiriboga AS; Flanagan EP
Semin Neurol; 2018 Jun; 38(3):392-402. PubMed ID: 30011418
[TBL] [Abstract][Full Text] [Related]
31. [The diagnostic challenge of autoimmune encephalitis].
Di Liberto G; Uginet M; Lalive PH; Du Pasquier R
Rev Med Suisse; 2024 Apr; 20(871):822-827. PubMed ID: 38665101
[TBL] [Abstract][Full Text] [Related]
32. Challenging diagnosis and treatment decision of a long-history autoantibody-negative autoimmune encephalitis.
Calvat P; Leung C; Bost C; Fortenfant F; Simonetta-Moreau M; Pariente J; Rafiq M; Brefel-Courbon C; Rascol O; Fabbri M; Ory-Magne F
Parkinsonism Relat Disord; 2023 Feb; 107():105232. PubMed ID: 36509623
[No Abstract] [Full Text] [Related]
33. [Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment].
Lewerenz J; Jarius S; Wildemann B; Wandinger KP; Leypoldt F
Nervenarzt; 2016 Dec; 87(12):1293-1299. PubMed ID: 27847964
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiological Effects of Autoantibodies in Autoimmune Encephalitides.
Ryding M; Mikkelsen AW; Nissen MS; Nilsson AC; Blaabjerg M
Cells; 2023 Dec; 13(1):. PubMed ID: 38201219
[TBL] [Abstract][Full Text] [Related]
35. "Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?".
Lapucci C; Benedetti L; Tavarelli C; Serrati C; Godani M; Schenone A; Franciotta D
Clin Neurol Neurosurg; 2019 Sep; 184():105424. PubMed ID: 31330415
[TBL] [Abstract][Full Text] [Related]
36. Role of the pathologist in the diagnosis of autoimmune encephalitis.
Rao S; Netravathi M; Mahadevan A
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S198-S206. PubMed ID: 35562150
[TBL] [Abstract][Full Text] [Related]
37. Seronegative Autoimmune Encephalitis with Evanescent Focal T2FLAIR Lesions.
Stewart C; Tung GA
R I Med J (2013); 2024 Mar; 107(3):14-15. PubMed ID: 38412347
[No Abstract] [Full Text] [Related]
38. Autoimmune encephalitis and paraneoplastic syndromes in Turkey: a multi-centre study.
Gozubatik-Celik RG; Gul ZB; Bilgin EB; Yildiz MU; Yenidunya O; Misirli H; Celik HT; Kurtulus F; Yaman A; Domac F; Karaci R; Cokar O; Culha Oktar A; Emre Toprak U; Yavuz N; Dalgıc E; Ozen Barut B; Dogan Ak P; Ozgenc CI; Bulbul NG; Atmaca MM; Gokyigit FM; Gürkan ZM; Pazarci N; Surmeli R; Kale N; Yildirim Z; Yayla V; Sozer N; Cabalar M; Delen F; Ucler S; Unal E; Sungur MA; Sen A; Atakli D; Soysal A
Neurol Sci; 2022 Jul; 43(7):4393-4403. PubMed ID: 35211811
[TBL] [Abstract][Full Text] [Related]
39. Clinical Sensitivity, Specificity, and Predictive Value of Neural Antibody Testing for Autoimmune Encephalitis.
Budhram A; Yang L; Bhayana V; Mills JR; Dubey D
J Appl Lab Med; 2022 Jan; 7(1):350-356. PubMed ID: 34996087
[No Abstract] [Full Text] [Related]
40. Acute symptomatic seizures, epilepsy, and autoimmune encephalitis: Clarifying terminology in neural antibody-associated disease.
Budhram A; Burneo JG
Epilepsia; 2023 Feb; 64(2):306-310. PubMed ID: 36471647
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
